Literature DB >> 3379202

Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology.

H J Trappe1, P Brugada, M Talajic, P Della Bella, R Lezaun, R Mulleneers, H J Wellens.   

Abstract

The prognosis of 149 patients with ventricular tachycardia (n = 108) or ventricular fibrillation (n = 41) was analyzed to assess the importance of the underlying etiology of the arrhythmia. Seventy-three patients (Group I) had a previous myocardial infarction and documented late sustained monomorphic ventricular tachycardia. Thirty-five (Group II) also had a previous myocardial infarction but had late ventricular fibrillation. There were 41 patients (Group III) without coronary artery disease: 9 patients with right ventricular dysplasia, 26 with idiopathic sustained ventricular tachycardia and 6 with idiopathic ventricular fibrillation. The mean follow-up period for all patients was 22 to 57 months. The total mortality rate in Group I (16%) and Group II (34%) and the arrhythmic mortality rate in Group I (5%) and Group II (11%) were significantly higher than the rates in Group III. In the latter group the total mortality rate was 4% for those with idiopathic ventricular tachycardia and 11% for those with right ventricular dysplasia, and there were no deaths due to arrhythmia (p less than 0.05). Left ventricular ejection fraction was significantly lower and left ventricular end-diastolic pressure was significantly higher in Group I and Group II than in Group III. There were nonfatal recurrences of ventricular tachycardia in 33 to 56% of patients, and the number of these episodes did not differ significantly in those with and without coronary artery disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3379202     DOI: 10.1016/0735-1097(88)90370-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Maternal cardiac arrhythmias during pregnancy and lactation.

Authors:  Rachael Cordina; Mark A McGuire
Journal:  Obstet Med       Date:  2010-03-04

2.  Sotalol in patients with life-threatening ventricular tachyarrhythmias.

Authors:  H J Trappe; H Klein; P Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 3.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

4.  Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.

Authors:  H J Crijns; A C Wiesfeld; J L Posma; K I Lie
Journal:  Br Heart J       Date:  1995-10

Review 5.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

Review 6.  Ventricular Tachycardia Ablation Guided by Functional Substrate Mapping: Practices and Outcomes.

Authors:  Sara Vázquez-Calvo; Ivo Roca-Luque; Andreu Porta-Sánchez
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.